OxySure Systems Inc., a Frisco, Texas-based medical technology company, has unveiled plans to add a drone to its lineup of emergency medical, resuscitation and trauma solutions for first-response markets.
According to the company's petition for Section 333 exemption from the Federal Aviation Administration (FAA), the drones would be ‘utilized in aerial operations in support of emergency response and services, disaster response and recovery, search and rescue, and humanitarian relief efforts.’ The company also filed a provisional patent with the U.S. Patent & Trademark Office (USPTO): ‘System for Enhancing Emergency Response by using Unmanned Aircraft Systems.’
OxySure expects the drones to carry kits designed for various types of emergency response, including automated external defibrillators and accessories for cardiac arrest, as well as kits for fire, flooding, first aid, dehydration, hypothermia, respiratory distress or chemical spills.
First-response entities would receive training prior to placing their equipment into service, the company notes.
“Historically, a big part of our focus has been to find ways to ‘bridge the gap’ – meaning the time between the onset of a medical emergency and the time that professional first responders arrive on the scene,” comments Julian Ross, CEO of OxySure. “Drones are the next logical step in that quest, and as it relates to all types of emergency categories, we believe they will enhance the existing operations of first responders.’